Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)
China · Delayed Price · Currency is CNY 23.50
+0.12 (0.51%)
At close: Feb 3, 2026
SHE:300702 Revenue
Zhejiang Tianyu Pharmaceutical had revenue of 719.55M CNY in the quarter ending September 30, 2025, with 7.91% growth. This brings the company's revenue in the last twelve months to 2.99B, up 15.07% year-over-year. In the year 2024, Zhejiang Tianyu Pharmaceutical had annual revenue of 2.63B with 4.10% growth.
Revenue (ttm)
2.99B
Revenue Growth
+15.07%
P/S Ratio
2.71
Revenue / Employee
658.78K
Employees
4,532
Market Cap
8.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.63B | 103.54M | 4.10% |
| Dec 31, 2023 | 2.53B | -139.41M | -5.23% |
| Jan 1, 2023 | 2.67B | 121.67M | 4.78% |
| Jan 1, 2022 | 2.55B | -42.39M | -1.64% |
| Dec 31, 2020 | 2.59B | 476.80M | 22.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Harbin Pharmaceutical Group | 15.94B |
| KPC Pharmaceuticals,Inc. | 7.35B |
| Zhejiang Xianju Pharmaceutical | 3.59B |
| Tianjin Ringpu Bio-Technology | 3.37B |
| Guilin Sanjin Pharmaceutical | 2.08B |
| Hubei Hongyuan Pharmaceutical Technology | 1.77B |
| Wanbangde Pharmaceutical Holding Group | 1.39B |
| Hainan Haiyao | 825.66M |